{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:14260"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:14260","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Investigations into parthenolide and boronic acid oxidation towards prodrug development","abstract":"Cancer is one of the leading causes of death worldwide. Current chemotherapy treatments display off-target effects leading to side effects. Through exploiting the intrinsic differences between healthy cells and cancerous cells, more targeted therapies can be developed using boronic ester oxidation chemistry. Examined in this work are the efforts made into understanding the fundamentals of boronic ester oxidation chemistry, ultimately to inform design of cancer therapy prodrugs. For a starting lead compound, as many drugs on the market are derived from natural products, this work also discusses the scope for using parthenolide as a leukaemia therapy. Supporting information for the thesis can be accessed https://edata.bham.ac.uk/966/","abstract_html":"Cancer is one of the leading causes of death worldwide. Current chemotherapy treatments display off-target effects leading to side effects. Through exploiting the intrinsic differences between healthy cells and cancerous cells, more targeted therapies can be developed using boronic ester oxidation chemistry. Examined in this work are the efforts made into understanding the fundamentals of boronic ester oxidation chemistry, ultimately to inform design of cancer therapy prodrugs. For a starting lead compound, as many drugs on the market are derived from natural products, this work also discusses the scope for using parthenolide as a leukaemia therapy. Supporting information for the thesis can be accessed https://edata.bham.ac.uk/966/","abstract_has_math":false,"creators":["Quy, Alexander S."],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-12","date_published":"2023-12","updated_at":"2026-11-19T09:32:33Z","subjects":["Q Science (General)","QM Human anatomy","RZ Other systems of medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/14260/7/Quy2023PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A14260","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Quy, Alexander S."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2023-12-06"]},{"key":"dc:date.issued","label":"Date","values":["2023-12"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Engineering & Physical Sciences","School of Chemistry"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/14260/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Q Science (General)","QM Human anatomy","RZ Other systems of medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/14260/7/Quy2023PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cancer is one of the leading causes of death worldwide. Current chemotherapy treatments display off-target effects leading to side effects. Through exploiting the intrinsic differences between healthy cells and cancerous cells, more targeted therapies can be developed using boronic ester oxidation chemistry. Examined in this work are the efforts made into understanding the fundamentals of boronic ester oxidation chemistry, ultimately to inform design of cancer therapy prodrugs. For a starting lead compound, as many drugs on the market are derived from natural products, this work also discusses the scope for using parthenolide as a leukaemia therapy. Supporting information for the thesis can be accessed https://edata.bham.ac.uk/966/"]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Investigations into parthenolide and boronic acid oxidation towards prodrug development"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Quy, Alexander S."],"dc:date":["2023-12-06"],"dc:date.issued":["2023-12"],"dc:description.abstract":["Cancer is one of the leading causes of death worldwide. Current chemotherapy treatments display off-target effects leading to side effects. Through exploiting the intrinsic differences between healthy cells and cancerous cells, more targeted therapies can be developed using boronic ester oxidation chemistry. Examined in this work are the efforts made into understanding the fundamentals of boronic ester oxidation chemistry, ultimately to inform design of cancer therapy prodrugs. For a starting lead compound, as many drugs on the market are derived from natural products, this work also discusses the scope for using parthenolide as a leukaemia therapy. Supporting information for the thesis can be accessed https://edata.bham.ac.uk/966/"],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/14260/7/Quy2023PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Engineering & Physical Sciences","School of Chemistry"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/14260/"],"dc:subject":["Q Science (General)","QM Human anatomy","RZ Other systems of medicine"],"dcterms:accessrights":["public"],"dc:title":["Investigations into parthenolide and boronic acid oxidation towards prodrug development"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:32:33Z"}